IMP
Process View
regulation of glomerular mesangial cell proliferation
Any process that modulates the frequency, rate or extent of glomerular mesangial cell proliferation.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of glomerular mesangial cell proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1.000 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | ||
| NRP1 | neuropilin 1 | 1.000 | ||
| VEGFA | vascular endothelial growth factor A | 0.999 | Human | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.997 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.986 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.958 | ||
| PGF | placental growth factor | 0.932 | Human | |
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.902 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.841 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.736 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.731 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.672 | ||
| PDGFC | platelet derived growth factor C | 0.501 | ||
| NOG | noggin | 0.482 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.423 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.403 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.358 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.354 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.280 | ||
| EGR3 | early growth response 3 | 0.230 | ||
| EGR2 | early growth response 2 | 0.221 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.204 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.203 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.202 | ||
| LDLR | low density lipoprotein receptor | 0.198 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.174 | ||
| IER2 | immediate early response 2 | 0.161 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.160 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.151 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.150 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.107 | ||
| BMP4 | bone morphogenetic protein 4 | 0.077 | ||
| JUND | jun D proto-oncogene | 0.074 | ||
| ATF3 | activating transcription factor 3 | 0.071 | ||
| BMP2 | bone morphogenetic protein 2 | 0.058 | Human | |
| DDIT4 | DNA-damage-inducible transcript 4 | 0.054 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.052 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.049 | ||
| DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.046 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.042 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.037 | ||
| MDFI | MyoD family inhibitor | 0.037 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.037 | ||
| BTG2 | BTG family, member 2 | 0.035 | ||
| HMGA1 | high mobility group AT-hook 1 | 0.032 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.031 | ||
| TAOK1 | TAO kinase 1 | 0.031 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.028 | ||
| ZNF205 | zinc finger protein 205 | 0.028 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.025 | ||
| TBX2 | T-box 2 | 0.025 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.025 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.025 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.024 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.023 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.023 | ||
| SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | 0.023 | ||
| STC2 | stanniocalcin 2 | 0.022 | ||
| NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) | 0.022 | ||
| FOXF1 | forkhead box F1 | 0.021 | ||
| BMP6 | bone morphogenetic protein 6 | 0.021 | Human | |
| DUSP6 | dual specificity phosphatase 6 | 0.020 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.020 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.020 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.019 | ||
| NPM3 | nucleophosmin/nucleoplasmin 3 | 0.019 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.019 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.019 | ||
| TRIB1 | tribbles homolog 1 (Drosophila) | 0.018 | ||
| ZNF420 | zinc finger protein 420 | 0.018 | ||
| VEGFC | vascular endothelial growth factor C | 0.018 | Human | |
| COL4A2 | collagen, type IV, alpha 2 | 0.018 | ||
| NRP2 | neuropilin 2 | 0.017 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.016 | ||
| EDN1 | endothelin 1 | 0.016 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.016 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.016 | ||
| INHBB | inhibin, beta B | 0.016 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.015 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.015 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.015 | ||
| EFNB3 | ephrin-B3 | 0.015 | ||
| SOSTDC1 | sclerostin domain containing 1 | 0.015 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.015 | ||
| BMP3 | bone morphogenetic protein 3 | 0.015 | Human | |
| WNT2 | wingless-type MMTV integration site family member 2 | 0.015 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.014 | ||
| PITX2 | paired-like homeodomain 2 | 0.014 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.014 | ||
| STC1 | stanniocalcin 1 | 0.014 | ||
| FGF4 | fibroblast growth factor 4 | 0.014 | ||
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.014 | ||
| HAND1 | heart and neural crest derivatives expressed 1 | 0.013 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.013 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.013 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.012 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.012 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.012 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.012 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.012 | ||
| G0S2 | G0/G1switch 2 | 0.012 | ||
| THBS1 | thrombospondin 1 | 0.012 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.012 | ||
| AES | amino-terminal enhancer of split | 0.012 | ||
| FOXF2 | forkhead box F2 | 0.012 | ||
| SNTA1 | syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component) | 0.012 | ||
| CA9 | carbonic anhydrase IX | 0.012 | ||
| FSTL1 | follistatin-like 1 | 0.012 | ||
| CD163 | CD163 molecule | 0.012 | ||
| SOX21 | SRY (sex determining region Y)-box 21 | 0.011 | ||
| JUNB | jun B proto-oncogene | 0.011 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.011 | ||
| HS3ST2 | heparan sulfate (glucosamine) 3-O-sulfotransferase 2 | 0.011 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.011 | ||
| GDNF | glial cell derived neurotrophic factor | 0.011 | ||
| CEP164 | centrosomal protein 164kDa | 0.011 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.011 | ||
| ACAN | aggrecan | 0.011 | ||
| HRH3 | histamine receptor H3 | 0.011 | ||
| GPC3 | glypican 3 | 0.011 | ||
| FST | follistatin | 0.011 | ||
| TG | thyroglobulin | 0.011 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.011 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.011 | ||
| CAV3 | caveolin 3 | 0.011 | ||
| COL13A1 | collagen, type XIII, alpha 1 | 0.011 | ||
| ALX4 | ALX homeobox 4 | 0.011 | ||
| VLDLR | very low density lipoprotein receptor | 0.011 | ||
| GJD2 | gap junction protein, delta 2, 36kDa | 0.011 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.011 | ||
| TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0.011 | ||
| CD34 | CD34 molecule | 0.011 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.011 | Human | |
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.011 | ||
| PTCH1 | patched 1 | 0.011 | ||
| IL11 | interleukin 11 | 0.011 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.010 | ||
| IER5 | immediate early response 5 | 0.010 | ||
| MYST1 | MYST histone acetyltransferase 1 | 0.010 | ||
| BMP8B | bone morphogenetic protein 8b | 0.010 | Human | |
| AQP5 | aquaporin 5 | 0.010 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.010 | ||
| GJA5 | gap junction protein, alpha 5, 40kDa | 0.010 | ||
| HAS2 | hyaluronan synthase 2 | 0.010 | ||
| COL4A6 | collagen, type IV, alpha 6 | 0.010 | ||
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.010 | ||
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.010 | ||
| EFNB2 | ephrin-B2 | 0.010 |